Entity Common Stock, Shares Outstanding of Design Therapeutics, Inc. from Q1 2021 to Q3 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Design Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and change rate from Q1 2021 to Q3 2025.
  • Design Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending October 31, 2025 was 57M shares, a 0.61% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Design Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 57M +343K +0.61% Oct 31, 2025 10-Q 2025-11-05
Q2 2025 56.9M +328K +0.58% Aug 1, 2025 10-Q 2025-08-07
Q1 2025 56.8M +268K +0.48% Mar 6, 2025 10-K 2025-03-10
Q3 2024 56.6M +619K +1.11% Nov 4, 2024 10-Q 2024-11-07
Q2 2024 56.6M +634K +1.13% Aug 1, 2024 10-Q 2024-08-05
Q1 2024 56.5M +551K +0.99% Mar 14, 2024 10-K 2024-03-19
Q3 2023 56M +91.9K +0.16% Nov 8, 2023 10-Q 2023-11-13
Q2 2023 56M +179K +0.32% Aug 9, 2023 10-Q 2023-08-14
Q1 2023 55.9M +243K +0.44% Mar 9, 2023 10-K 2023-03-14
Q3 2022 55.9M +248K +0.45% Nov 1, 2022 10-Q 2022-11-03
Q2 2022 55.8M +191K +0.34% Aug 3, 2022 10-Q 2022-08-08
Q1 2022 55.7M +82.8K +0.15% Mar 4, 2022 10-K 2022-03-10
Q3 2021 55.7M Nov 5, 2021 10-Q 2021-11-09
Q2 2021 55.6M Jul 31, 2021 10-Q 2021-08-09
Q1 2021 55.6M Apr 30, 2021 10-Q 2021-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.